Want to see DH full AI Analyst Report?
DH Stock Chart & Stats
$0.75
>-$0.01(-1.38%)
At close: 4:00 PM EDT
$0.75
>-$0.01(-1.38%)
Day’s Range― - ―
52-Week Range$0.61 - $4.24
Previous Close$0.69
Volume106.08K
Average Volume (3M)818.66K
Market Cap
$128.91M
Enterprise Value$114.59
Total Cash (Recent Filing)$183.59M
Total Debt (Recent Filing)$167.06M
Price to Earnings (P/E)―
Beta1.54
Next Earnings
Nov 05, 2026EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding106,744,710
10 Day Avg. Volume974,890
30 Day Avg. Volume818,659
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.26
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$1.70Price Target Upside126.67% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)0.2
Revenue Forecast (FY)$221.23M
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationPositive operating and free cash flow despite reported net losses gives Definitive Healthcare internal funding capacity. This supports product investment, debt reduction, and customer initiatives without relying entirely on external capital, although recent conversion softness warrants monitoring.
Improved LeverageLower leverage reduces financial strain and improves the company’s ability to withstand revenue volatility while preserving options for investment or strategic transactions. A stronger balance sheet can also make recurring cash generation more useful because less cash is required for debt servicing.
Product And AI InnovationEmbedding AI into healthcare intelligence products could strengthen customer retention and expand the platform’s long-term usefulness. Although management does not expect material 2026 revenue from Turbo, pilot adoption creates a product-led pathway for future differentiation and 2027 growth.
Bears Say
Persistent Revenue ContractionSustained top-line contraction indicates that customer demand and commercial execution remain under pressure rather than reflecting only a single-quarter fluctuation. Lower revenue can restrict operating leverage, reduce reinvestment capacity, and make the company’s path to durable earnings growth less certain.
Lower Revenue VisibilityDeclining deferred revenue and remaining performance obligations reduce the amount of contracted business supporting future periods. The shift from multi-year to single-year deals also makes renewals more consequential and increases exposure to ongoing budget or demand changes among customers.
Ongoing Net LossesStrong gross margins show that the core data offering can produce attractive revenue economics, but persistent net losses indicate operating and non-operating costs still absorb that gross profit. Until profitability becomes durable, capital allocation and resilience remain constrained during periods of weaker growth.
Definitive Healthcare Corp News
DH FAQ
What was Definitive Healthcare Corp’s price range in the past 12 months?
Definitive Healthcare Corp lowest stock price was $0.61 and its highest was $4.24 in the past 12 months.
What is Definitive Healthcare Corp’s market cap?
Definitive Healthcare Corp’s market cap is $128.91M.
When is Definitive Healthcare Corp’s upcoming earnings report date?
Definitive Healthcare Corp’s upcoming earnings report date is Nov 05, 2026 which is in 42 days.
How were Definitive Healthcare Corp’s earnings last quarter?
Definitive Healthcare Corp released its earnings results on Aug 10, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.043 by $0.007.
Is Definitive Healthcare Corp overvalued?
According to Wall Street analysts Definitive Healthcare Corp’s price is currently Undervalued.
Does Definitive Healthcare Corp pay dividends?
Definitive Healthcare Corp does not currently pay dividends.
What is Definitive Healthcare Corp’s EPS estimate?
Definitive Healthcare Corp’s EPS estimate is 0.04.
How many shares outstanding does Definitive Healthcare Corp have?
Definitive Healthcare Corp has 106,744,710 shares outstanding.
What happened to Definitive Healthcare Corp’s price movement after its last earnings report?
Definitive Healthcare Corp reported an EPS of $0.05 in its last earnings report, beating expectations of $0.043. Following the earnings report the stock price went down -7.88%.
Which hedge fund is a major shareholder of Definitive Healthcare Corp?
Currently, no hedge funds are holding shares in DH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Definitive Healthcare Corp Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-79.30%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-35.49%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Definitive Healthcare Corp
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
DH Company Deck
DH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: clear near‑term top‑line pressures (Q2 revenue down 9% YoY, RPO and deferred revenue down double digits, professional services softness, and continued life sciences drag) alongside strong profitability, disciplined cost management, robust free cash flow (~$50M TTM), operational progress (integrations, win‑backs, digital activation growth), and product/AI momentum (Turbo pilot and AI embedding). Management tightened full‑year revenue guidance while raising profit/margin guidance and emphasized that improvements in net dollar retention and customer win‑backs underpin confidence in a return to growth over time.View all DH earnings summariesDH Stock 12 Month Forecast
Average Price Target
$1.70
▲(126.67% Upside)
Technical Analysis
Ownership Overview
11.13% Insiders
3.81% Mutual Funds
61.67% Other Institutional Investors
19.07% Public Companies and
Individual Investors